MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma

NCT04013334 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: MTG201
DRUG: Nivolumab Injection [Opdivo]

Sponsor

Momotaro-Gene Inc.

Collaborators

[object Object]
[object Object]